Physician profile
Benjamin Rosen
NPI 1821416785
$1,657.25
in general payments reported to CMS, 2019-2025
19 companies · $442 in 2025
The $442 reported for 2025 was more than what 78% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $179 · 2022: $148 · 2023: $492 · 2024: $396 · 2025: $442.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,331.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,330.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $536.78 | 2021-2025 | |
| Genzyme Corporation | $342.09 | 2023-2025 | |
| Regeneron Healthcare Solutions, INC. | $185.42 | 2021-2024 | Dupixent |
| Pfizer INC. | $149.50 | 2021-2025 | |
| Leo Pharma INC. | $68.09 | 2024-2025 | Adbry |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $61.53 | 2023-2024 | Jublia |
| Lilly USA, LLC | $58.32 | 2023-2024 | Taltz, Olumiant, Ebglyss |
| Janssen Biotech, INC. | $52.30 | 2022-2024 | Tremfya |
| Novartis Pharmaceuticals Corporation | $48.48 | 2025 | |
| Incyte Corporation | $29.90 | 2021-2024 | Opzelura |
| E.R. Squibb & Sons, L.L.C. | $22.70 | 2022 | |
| Epi Health, LLC | $16.12 | 2021 | |
| Mayne Pharma Commercial LLC | $15.60 | 2025 | |
| Sun Pharmaceutical Industries INC. | $14.23 | 2025 | |
| Dermavant Sciences, INC. | $13.21 | 2023 | Vtama |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arcutis Biotherapeutics, INC. | $13.10 | 2023 | |
| Amgen INC. | $12.81 | 2023 | Otezla, Enbrel |
| Almirall LLC | $11.89 | 2021 | |
| Organon LLC | $5.18 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Rosen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.